Daniel Kopp is an intellectual property attorney with more than 15 years of experience in patent prosecution and counseling, primarily in small molecule pharmaceuticals. Prior roles include in-house positions at global biopharmaceutical companies, where he advised on patent issues spanning lead identification, pre-clinical and clinical development, commercialization, and life-cycle management.
Working in complex, multi-party collaborations, Daniel is skilled at transactions and building relationships.
He has additional technical expertise in nanomaterials in optical, solar energy, and pharmaceutical applications.
- Biogen, IP Counsel
- AstraZeneca, Senior Patent Attorney
- Venable LLP, Associate
- Steptoe & Johnson, LLP, Associate; Patent Agent/Technology Specialist
The George Washington University Law School, J.D.
- Merit Scholarship
Massachusetts Institute of Technology, Ph.D.
William & Mary, B.S.
- Chemistry and Biology
- magna cum laude
- District of Columbia
- U.S. Patent and Trademark Office (USPTO)